Publications by authors named "Benjamin Miron"

Claim this Profile
I
Impact of Renal Function Eligibility Criteria on Clinical Trials and Real-World Survival Outcomes Among Patients With Metastatic Renal Cell Carcinoma.
Xiaoliang Wang, Jill Hasler, Benjamin Miron, Mengru Wang, Anosheh Afghahi

Clin Genitourin Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Outcomes in Patients With Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Chemotherapy Stratified by Number of Cycles.
Anumita Chakraborty, Jill Hasler, Elizabeth Handorf, Fern Anari, Pooja Ghatalia, Benjamin Miron

Clin Genitourin Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary role of avelumab first-line maintenance in advanced urothelial carcinoma with consideration of the JAVELIN Bladder 100 comprehensive clinical subgroup analyses.
Kevin K Zarrabi, Benjamin Miron, Daniel M Geynisman

Transl Androl Urol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Genomic Landscape of Urothelial Carcinoma with High and Low Expression.
Agreen Hadadi, Harris B Krause, Andrew Elliott, Jacqueline T Brown, Bassel Nazha, Benjamin Miron

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer.
Kevin K Zarrabi, Vivek Narayan, Patrick J Mille, Matthew R Zibelman, Benjamin Miron

Ther Adv Urol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Meta-analysis of Urine Microbiome: Colonization of Polycyclic Aromatic Hydrocarbon-degrading Bacteria Among Bladder Cancer Patients.
Laura Bukavina, Ilaha Isali, Rashida Ginwala, Mohit Sindhani, Adam Calaway, Benjamin Miron

Eur Urol Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma.
Kevin K Zarrabi, Elizabeth Handorf, Benjamin Miron, Matthew R Zibelman, Fern Anari

Oncologist· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bempegaldesleukin/Nivolumab and Challenges in First-line Treatment of Metastatic Urothelial Carcinoma.
Benjamin Miron, Daniel M Geynisman

Eur Urol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of first-line chemotherapy regimen on survival outcomes of patients with advanced urothelial carcinoma who received second-line immune checkpoint inhibitors.
Benjamin Miron, Elizabeth Handorf, Kevin Zarrabi, Matthew R Zibelman, Fern Anari

Urol Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic limbic encephalitis following treatment with single-agent pembrolizumab for advanced gastroesophageal adenocarcinoma.
Lauren Laderman, Omer Naveed, Carla LoPinto-Khoury, Efrat Dotan, Benjamin Miron

BMJ Case Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placing Adjuvant Chemotherapy in the Evolving Paradigm of Perioperative Therapy for Bladder Cancer.
Benjamin Miron, Laura Bukavina, Elizabeth R Plimack

Eur Urol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Functional Characterization of Atypical / Mutations in Metastatic Colorectal Cancer.
Jonathan M Loree, Yucai Wang, Muddassir A Syed, Alexey V Sorokin, Oluwadara Coker, Benjamin Miron

Clin Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker Development for Metastatic Renal Cell Carcinoma: Omics, Antigens, T-cells, and Beyond.
Benjamin Miron, David Xu, Matthew Zibelman

J Pers Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.
Benjamin Miron, Jean H Hoffman-Censits, Fern Anari, John O'Neill, Daniel M Geynisman

Eur Urol Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisited analysis of a SHIVA01 trial cohort using functional mutational analyses successfully predicted treatment outcome.
Maud Kamal, Gabi Tarcic, Sylvain Dureau, Oded Edelheit, Zohar Barbash, Benjamin Miron

Mol Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subclonal Therapy by Two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR-Mutated Lung Cancer.
Nir Peled, Laila C Roisman, Benjamin Miron, Raphael Pfeffer, Richard B Lanman

J Thorac Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biology is Destiny: A Case of Adrenocortical Carcinoma Diagnosed and Resected at Inception in a Patient Under Close Surveillance for Lung Cancer.
Benjamin Miron, Benjamin T Ristau, Jeffrey J Tomaszewski, Josh Jones, Bart Milestone

Urol Case Rep· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus.
David H Ilson, David Kelsen, Manish Shah, Gary Schwartz, Douglas A Levine, Benjamin Miron

Cancer· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis